tm logo
VYXARIQ
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 07 Oct 2024

Last Applicant/ Owned by

545 Fifth Avenue, Suite 1400

New York

NY

10017

Serial Number

98787901 filed on 07th Oct 2024

Registration Number

N/A

Correspondent Address

Anna Kurian Shaw

Anna Kurian Shaw Hogan Lovells US LLP

Washington, DC 20004

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

VYXARIQ

Pharmaceutical preparations for treatment of diabetes complications; Pharmaceutical preparations for treatment of heart diseases or disorders, eye diseases or disorders, nervous system diseases or disorders, kidney diseases or disorders, cardiomyopathy, neuropathy, retinopathy, and nephropathy; Pharmaceutical preparations for inhibiting aldose reductase

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for treatment of diabetes complications; Pharmaceutical preparations for treatment of heart diseases or disorders, eye diseases or disorders, nervous system diseases or disorders, kidney diseases or disorders, cardiomyopathy, neuropathy, retinopathy, and nephropathy; Pharmaceutical preparations for inhibiting aldose reductase


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98787901

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 761350.00238

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
07th Oct 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07th Oct 2024NEW APPLICATION ENTERED